Medipal Holdings Raises Recognized Cost of Capital to 6%-7%

PUBT · 1d ago
Medipal Holdings Raises Recognized Cost of Capital to 6%-7%
  • Medipal Holdings' board resolved on November 5, 2026, to revise its cost-of-capital assessment and target returns consistently exceeding that cost.
  • The benchmark shifts from weighted average cost of capital to cost of equity, raising the recognized level to approximately 6%–7%.
  • Investment evaluations will become more rigorous, with a system established to verify post-investment progress and results.
  • An October 23, 2026, board resolution authorized treasury stock purchases of up to 10 billion yen and cancellation of acquired shares.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Medipal Holdings Corporation published the original content used to generate this news brief on November 05, 2026, and is solely responsible for the information contained therein.